Skip to Content
Merck
CN

New insights into DNA-binding by type IIA topoisomerases.

Current opinion in structural biology (2012-12-26)
Chih-Chiang Chang, Ying-Ren Wang, Shin-Fu Chen, Chyuan-Chuan Wu, Nei-Li Chan
ABSTRACT

Type IIA topoisomerases catalyze the passage of two DNA duplexes across each other to resolve the entanglements and coiling of cellular DNA. The ability of these enzymes to interact simultaneously but differentially with two DNA segments is central to their DNA-manipulating functions: one duplex DNA is bound and cleaved to produce a transient double-strand break through which another DNA segment can be transported. Recent structural analyses have revealed in atomic detail how type IIA enzymes contact DNA and how the enzyme-DNA interactions may be exploited by drugs to achieve therapeutic purposes. This review summarizes these new findings, with a special focus on the assembly and structural features of the enzymes' composite DNA-binding surfaces.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Topoisomerase II α human, (Single band on SDS-PAGE), liquid
Sigma-Aldrich
L-Isoleucine, 99%, FCC, FG
Sigma-Aldrich
L-Isoleucine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
DNA Gyrase from Escherichia coli, aqueous glycerol solution
Sigma-Aldrich
Topoisomerase I human, buffered aqueous glycerol solution, ≥2 units/μL
SAFC
L-Isoleucine
Sigma-Aldrich
L-Isoleucine, reagent grade, ≥98% (HPLC)
Supelco
L-Isoleucine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Supelco
L-Isoleucine, Pharmaceutical Secondary Standard; Certified Reference Material